跳至主要内容
临床试验/EUCTR2016-002176-27-ES
EUCTR2016-002176-27-ES
进行中(未招募)
1 期

Pragmatic, prospective, randomized, controlled, double-blind, multicentre, multinational study on the safety and efficacy of a 6% Hydroxyethyl starch (HES) solution versus an electrolyte solution in trauma patients - TETHYS

B. Braun Melsungen AG0 个研究点目标入组 350 人2017年4月21日

概览

阶段
1 期
干预措施
未指定
疾病 / 适应症
未指定
发起方
B. Braun Melsungen AG
入组人数
350
状态
进行中(未招募)
最后更新
7年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2017年4月21日
结束日期
待定
最后更新
7年前
研究类型
Interventional clinical trial of medicinal product
性别
All

研究者

入排标准

入选标准

  • Male or female adult patients \= 18 and \= 80 years of age
  • Women of childbearing potential must test negative on standard pregnancy test (urine or serum)
  • Patients with blunt or penetrating trauma suffering from an estimated blood loss of \= 500 ml
  • Initial surgery deemed necessary within 24 hours after trauma
  • Deferred signed written informed consent form or as locally required
  • No signs of intracranial or cerebral haemorrhage
  • Base excess \< \- 4 mEq/l
  • Administration of less than 15 ml/kg body weight colloid between trauma injury and hospital admission
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:

排除标准

  • Hypersensitivity to the active substances or to any of the other excipients of the investigational products
  • Body weight \= 140 kg
  • Patients expected to die within 24 hours after traumatic injury
  • Renal impairment (AKIN stage \= 1\) or acute and/or chronic renal replacement therapy
  • Critically ill patients (typically admitted to the intensive care unit)
  • Dehydration
  • Hyperhydration
  • Pulmonary oedema
  • Congestive heart failure
  • Hyperkalaemia

结局指标

主要结局

未指定

相似试验

进行中(未招募)
1 期
Pragmatic, controlled, international study conducted in several centres on the safety and therapeutic effect of a Hydroxylethyl-starch (HES) solution versus an electrolyte solution in trauma patients
EUCTR2016-002176-27-CZFresenius Kabi Deutschland GmbH350
已完成
4 期
Pragmatic, prospective, randomized, controlled, double-blind, multicentre, multinational study on the safety and efficacy of a 6% Hydroxyethyl starch (HES) solution versus an electrolyte solution in trauma patients'Hypovolaemia' and 'Decreased blood volume'10014412
NL-OMON50632PRA Belgium BV50
进行中(未招募)
1 期
Pragmatic, controlled, international study conducted in several centres on the safety and therapeutic effect of a Hydroxylethyl-starch (HES) solution versus an electrolyte solution in trauma patientsHypovolaemia due to acute blood loss in trauma surgeryMedDRA version: 20.0Level: PTClassification code 10021137Term: HypovolaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Injuries, poisonings, and occupational diseases [C21]
EUCTR2016-002176-27-NLFresenius Kabi Deutschland GmbH350
进行中(未招募)
1 期
Pragmatic, controlled, international study conducted in several centres on the safety and therapeutic effect of a Hydroxylethyl starch (HES) solution versus an electrolyte solution in trauma patients
EUCTR2016-002176-27-DEFresenius Kabi Deutschland GmbH262
进行中(未招募)
1 期
Pragmatic, controlled, international study conducted in several centres on the safety and therapeutic effect of a Hydroxylethyl-starch (HES) solution versus an electrolyte solution in trauma patients
EUCTR2016-002176-27-FRB. Braun Melsungen AG350